{"transactions":[{"id":711022,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-10T20:15:05.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier to occur of (i) July 8, 2027 or (ii) the day immediately prior to the first annual meeting of the Company's stockholders occurring after July 8, 2026."}],"balance_after":6500,"derivative":{"exercise_price":7.14,"expiration_date":"2036-07-07","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001193125-26-300926","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000119312526300926/ownership.xml","form_type":"4"}},{"id":717189,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-02T22:09:52.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2026, January 1, 2027, April 1, 2027, and July 1, 2027, provided that if the issuer's 2027 annual meeting of stockholders occurs before July 1, 2027, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date."}],"balance_after":7508,"derivative":{"exercise_price":7.94,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":7508},"source":{"system":"sec-edgar","filing":"0001193125-26-295064","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000119312526295064/ownership.xml","form_type":"4"}},{"id":747459,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:41:26.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001645041-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645041/000164504126000002/primarydocument.xml","form_type":"4"}},{"id":1072944,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T20:10:04.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in four equal quarterly installments occurring on August 5, 2026, August 5, 2027, August 5, 2028, August 5, 2029, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":14.28,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-104016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000095017025104016/ownership.xml","form_type":"4"}},{"id":1117352,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:40:33.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 36 equal monthly installments beginning on July 5, 2025, provided that the reporting person provides continuous service to Sana Biotechnology, Inc. through each such date."}],"balance_after":115000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001562180-25-004647","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645041/000156218025004647/primarydocument.xml","form_type":"4"}},{"id":1390840,"issuer":{"id":83618,"kind":"organization","name":"Omega Therapeutics, Inc.","symbol":"OMGA"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T17:10:05.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":1.09,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-112971","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850838/000095017024112971/ownership.xml","form_type":"4"}},{"id":1858834,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T16:03:05.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant."}],"balance_after":30000,"derivative":{"exercise_price":0.11,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001694665-23-000082","document":"wk-form4_1686600177.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466523000082/wk-form4_1686600177.xml","form_type":"4"}},{"id":1918106,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-18T17:12:44.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years."}],"balance_after":40000,"derivative":{"exercise_price":0.17,"expiration_date":"2033-04-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-23-011385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000089924323011385/doc4.xml","form_type":"4"}},{"id":2109917,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-18T16:15:53.000Z","date":"2022-11-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in twelve equal quarterly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-11-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-120304","document":"tm2230943-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465922120304/tm2230943-1_4seq1.xml","form_type":"4"}},{"id":4530367,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corp Dev & Strategy"}}],"security":"Common Stock, no par value","published_at":"2016-12-07T21:40:23.000Z","date":"2016-12-05","kind":"tax_withholding","acquired":false,"shares":14687,"price":18,"value":264366.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":517683,"source":{"system":"sec-edgar","filing":"0001645041-16-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000164504116000003/primary_doc.xml","form_type":"4"}},{"id":4564678,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corp Dev & Strategy"}}],"security":"Common Stock, no par value","published_at":"2016-11-08T21:41:01.000Z","date":"2016-11-04","kind":"tax_withholding","acquired":false,"shares":817,"price":22.06,"value":18023.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":532370,"source":{"system":"sec-edgar","filing":"0001645041-16-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000164504116000002/primary_doc.xml","form_type":"4"}}]}